Michael D. West, Ph.D., President and Chief Scientific Officer of Advanced Cell Technology, Inc. (OTCBB:ACTH), will deliver the keynote presentation, “Embryonic Stem Cells and Nuclear Transfer: Challenges and Opportunities,” at the University of Toronto’s “ChaRM, Challenges in Regenerative Medicine” conference. Address will be delivered today at 1:45 p.m. EST in the Renaissance Toronto Hotel.
